NEW YORK--(BUSINESS WIRE)--The premier authority in the use of advanced imaging to diagnose prostate tumors and the utilization of MRI-guided transrectal focal laser ablation for treating these tumors, Dan Sperling, MD, D.A.B.R. points to the effectiveness of this innovative, minimally invasive procedure in virtually eliminating the risk of impotence— erectile dysfunction, or incontinence– loss of bladder control, associated with traditional forms of surgery and treatment. Prostate cancer is the most common non-skin malignancy and second-leading tumor-related cause of death in men.
